To definitively test the tumor suppressor activity of SRC-2 in MYC-mediated liver tumorigenesis in vivo and to further investigate the mechanism(s) through which this coactivator inhibits liver tumorigenesis, we examined the consequences of genetic deletion of Src-2 in a MYC-induced liver cancer model. This evidence concerns the gene MYC and neoplasm.